Eli Taube

Eli Taube

Head of the North America Clinical Operations Hub

Eli Taube is the Head of the North America Clinical Operations Hub at Servier Pharmaceuticals. Eli and his teams in the U.S. and Canada are responsible for the execution of Servier’s clinical studies in North America starting at investigational new drug enabling activities, planning, initiating and conduct of clinical studies, in addition to new drug application (NDA) and biologic licenses applications (BLA) supporting activities. Eli works to drive the team to develop and advance methodologies that will facilitate efficient planning and execution of clinical studies, enabling above benchmark delivery from study concept to NDA/ BLA filing.

Eli has held management positions across biotechnology and pharmaceutical companies including Baxter, Baxalta, Shire and Quintiles (IQVIA). His career is distinguished by a wide range of positions within clinical operation organizations from hands on positions up to therapeutic area team’s management. His mission is to enhance clinical operational teams’ knowledge of the clinical development cascade allowing them to influence all development steps with a focus on study design, regulatory and translational medicine aspects.

Eli received his Bachelor of Science in Biology and Masters of Science in Physiology from the Tel Aviv University in Israel.

To learn more about Eli connect with him on LinkedIn.

More from Servier

About Us

Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.

Learn More

Governance

Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.

Learn More

History

Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history. 

Learn More